Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of hydroxylated 2,4-diphenyl-6-aryl pyridines

被引:94
作者
Karki, Radha [3 ]
Thapa, Pritam [3 ]
Kang, Mi Jeong [3 ]
Jeong, Tae Cheon [3 ]
Nam, Jung Min [1 ,2 ]
Kim, Hye-Lin [1 ,2 ]
Na, Younghwa [4 ]
Cho, Won-Jea [5 ]
Kwon, Youngjoo [1 ,2 ]
Lee, Eung-Seok [3 ]
机构
[1] Ewha Womans Univ, Coll Pharm, Seoul 120750, South Korea
[2] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul 120750, South Korea
[3] Yeungnam Univ, Coll Pharm, Kyongsan 712749, South Korea
[4] Catholic Univ Daegu, Coll Pharm, Kyongsan 712702, South Korea
[5] Chonnam Natl Univ, Coll Pharm, Kwangju 500757, South Korea
关键词
Hydroxylated 2,4-diphenyl-6-aryl pyridines; Topoisomerase I and II inhibitor; Cytotoxicity; Anticancer agents; DNA TOPOISOMERASES; CANCER CELLS; DERIVATIVES; COMPLEXES; COVALENT; AGENTS;
D O I
10.1016/j.bmc.2010.03.051
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A new series of 2,4-diphenyl-6-aryl pyridines containing hydroxyl group(s) at the ortho, meta, or para position of the phenyl ring were synthesized, and evaluated for topoisomerase I and II inhibitory activity and cytotoxicity against several human cancer cell lines for the development of novel anticancer agents. Structure-activity relationship study revealed that the substitution of hydroxyl group( s) increased topoisomerase I and II inhibitory activity in the order of meta > para > ortho position. Substitution of hydroxyl group on the para position showed better cytotoxicity. (c) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3066 / 3077
页数:12
相关论文
共 31 条
[1]   2,4,6-Trisubstituted pyridines: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship [J].
Basnet, Arjun ;
Thapa, Pritam ;
Karki, Radha ;
Na, Younghwa ;
Jahng, Yurngdong ;
Jeong, Byeong-Seon ;
Jeong, Tae Cheon ;
Lee, Chong-Soon ;
Lee, Eung-Seok .
BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (13) :4351-4359
[2]   2,6-Dithienyl-4-furyl pyridines: Synthesis, topoisomerase I and II inhibition, cytotoxicity, structure-activity relationship, and docking study [J].
Basnet, Arjun ;
Thapa, Pritam ;
Karki, Radha ;
Choi, Hoyoung ;
Choi, Jae Hun ;
Yun, Minho ;
Jeong, Byeong-Seon ;
Jahng, Yurngdong ;
Na, Younghwa ;
Cho, Won-Jea ;
Kwon, Youngjoo ;
Lee, Chong-Soon ;
Lee, Eung-Seok .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (01) :42-47
[3]   Synthetic chalcones, flavanones, and flavones as antitumoral agents:: Biological evaluation and structure-activity relationships [J].
Cabrera, Mauricio ;
Simoens, Macarena ;
Falchi, Gabriela ;
Lavaggi, M. Laura ;
Piro, Oscar E. ;
Castellano, Eduardo E. ;
Vidal, Anabel ;
Azqueta, Amaia ;
Monge, Antonio ;
de Cerain, Adela Lopez ;
Sagrera, Gabriel ;
Scoane, Gustavo ;
Cerecetto, Hugo ;
Gonzalez, Mercedes .
BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (10) :3356-3367
[4]   Oxidation of DNA and RNA by oxoruthenium(IV) metallointercalators: Visualizing the recognition properties of dipyridophenazine by high-resolution electrophoresis [J].
Carter, PJ ;
Cheng, CC ;
Thorp, HH .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1998, 120 (04) :632-642
[5]   DNA topoisomerases: Structure, function, and mechanism [J].
Champoux, JJ .
ANNUAL REVIEW OF BIOCHEMISTRY, 2001, 70 :369-413
[6]   Resveratrol as a chemopreventive agent:: A promising molecule for fighting cancer [J].
Delmas, D ;
Lançon, A ;
Colin, D ;
Jannin, B ;
Latruffe, N .
CURRENT DRUG TARGETS, 2006, 7 (04) :423-442
[7]   Molecular modeling studies of the DNA-topoisomerase I ternary cleavable complex with camptothecin [J].
Fan, Y ;
Weinstein, JN ;
Kohn, KW ;
Shi, LM ;
Pommier, Y .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (13) :2216-2226
[8]  
Fukuda M, 1996, CANCER RES, V56, P789
[9]  
GIJN RV, 2000, J ONCOL PHARM PRACTI, V3, P92
[10]   Simple aromatic compounds containing propenone moiety show considerable dual COX/5-LOX inhibitory activities [J].
Jahng, Y ;
Zhao, LX ;
Moon, YS ;
Basnet, A ;
Kim, EK ;
Chang, HW ;
Ju, HK ;
Jeong, TC ;
Lee, ES .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (10) :2559-2562